Julien Fleurence
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Journal: Research square
Published: April 22, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Journal: Nature
Published: March 14, 2024
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.
Journal: Cancer immunology research
Published: April 19, 2019
Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside.
Journal: International journal of cancer
Published: February 14, 2019
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation.
Journal: Journal of visualized experiments : JoVE
Published: February 09, 2019
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
Journal: Journal of immunology research
Published: August 15, 2016
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
Journal: Oncotarget
Published: September 29, 2015
Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting.
Journal: Oncoimmunology
Published: January 18, 2013
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
Journal: PloS one
Published: May 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026